Table 4.

The comparison of liver and fat body weights among different groups.

	CG	MG	PIG	BG	BPG	BPIG	BPPIG
Body weight (g)	368.2 ± 32.7	397.4 ± 36.6	410.4 ± 47.5	390.3 ± 32.6	384.8 ± 28.9	394.7 ± 36.8	388.4 ± 33.2
Liver index (%)	2.6 ± 0.3	3.2 ± 0.4	3.4 ± 0.5	3.0 ± 0.3	2.8 ± 0.3	3.1 ± 0.3	2.9 ± 0.3
epididymal fat weight (g)	8.4 ± 1.3	9.8 ± 1.6	11.2 ± 1.8	9.1 ± 1.6	8.8 ± 1.3	9.3 ± 1.4	8.9 ± 1.5

Note: Liver index was presented as liver weight/body weight × 100%. All rat NASH models were evenly and randomly assigned to 6 groups: model group (MG, the model rats were intraperitoneally injected with 50 μL/kg saline solution and orally received 20 mL/kg liquid placebo daily); blueberry juice group (BG, the model rats were intraperitoneally injected with 50 μL/kg saline solution and orally received 10 mL/kg blueberry juice and 10 mL/kg liquid placebo daily); Blueberry juice and probiotic bacteria group (BPG, the model rats were intraperitoneally injected with 50 μL/kg normal saline solution and orally received 10 mL/kg blueberry juice and 10 mL/kg probiotics daily); PPAR-α inhibitor group (PIG, the model rats were intraperitoneally injected with 50 μL/kg PPAR-α in saline solution); blueberry juice and PPAR-α inhibitor group (BPIG, the model rats were intraperitoneally injected with 50 μL/kg PPAR-α in saline solution and orally received 10 mL/kg blueberry juice and 10 mL/kg liquid placebo daily); and blueberry juice, probiotics, and PPAR-α inhibitor group (BPPIG, the model rats were intraperitoneally injected with 50 μL/kg PPAR-α in saline solution and orally received 10 mL/kg blueberry juice and 10 mL/kg probiotics daily). Meanwhile, 8 healthy rats were used as a control group (CG, the healthy rats were intraperitoneally injected with 50 μL/kg normal saline solution and orally received 20 mL/kg liquid placebo daily).